A multinational, noninterventional study of tofacitinib in patients treated for psoriatic arthritis. TOPSATI. PFI-TOF-2020-01
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: PFIZER HOLDING FRANCE
- Execution start: 03/08/2022
- End of execution: 30/01/2024
- PI: ENRIQUE RAYA ALVAREZ